Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2025-12-24 @ 9:23 PM
NCT ID:
NCT01159132
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent
* Evidence of HIV infection
* Age\> 18 years
* On RAL 400 mg BID containing HAART regimen with a VL \< 50 copies for at least 3 months before enrollment
* Willing to adhere to the protocol requirements
Exclusion Criteria:
* Evidence of RAL resistance
* History of RAL allergy
* Use of concomitant medication that may interfere with the pharmacokinetics of RAL
* Current pregnancy or lactating or planning to get pregnant
* Active drug abuse or alcoholic
* Relevant history or current condition, illness that might interfere with drug absorption, distribution, metabolism or excretion.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01159132
Study Brief:
Protocol Section:
NCT01159132